Kovack Advisors, Inc. Humacyte, Inc. Transaction History

Kovack Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	BUY	$2.75 - $4.48 $5,500 - $8,960	2,000 Added 5.0%	42,000 $123,000
Q2 2023 Jul 21, 2023	BUY	$2.86 - $4.97 $14,300 - $24,850	5,000 Added 14.29%	40,000 $114,000
Q1 2023 Apr 20, 2023	BUY	$2.11 - $3.25 $21,100 - $32,500	10,000 Added 40.0%	35,000 $108,000
Q4 2022 Feb 22, 2023	BUY	$2.02 - $3.62 $50,500 - $90,500	25,000 New	25,000 $52,000
Q2 2022 Aug 10, 2022	SELL	$3.21 - $7.86 $101,115 - $247,590	-31,500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.65 - $7.4 $146,475 - $233,100	31,500 New	31,500 $222,000

149

35.1M

279K

607K

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $472M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Kovack Advisors, Inc. with notifications on news.